HomeCompareLVCLY vs FCPT

LVCLY vs FCPT: Dividend Comparison 2026

LVCLY yields 6535.95% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LVCLY wins by $847059858510467.75M in total portfolio value
10 years
LVCLY
LVCLY
● Live price
6535.95%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$847059858510467.75M
Annual income
$822,310,439,328,829,700,000.00
Full LVCLY calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — LVCLY vs FCPT

📍 LVCLY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLVCLYFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LVCLY + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LVCLY pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LVCLY
Annual income on $10K today (after 15% tax)
$555,555.56/yr
After 10yr DRIP, annual income (after tax)
$698,963,873,429,505,200,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, LVCLY beats the other by $698,963,873,429,505,200,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LVCLY + FCPT for your $10,000?

LVCLY: 50%FCPT: 50%
100% FCPT50/50100% LVCLY
Portfolio after 10yr
$423529929255233.88M
Annual income
$411,155,219,664,414,830,000.00/yr
Blended yield
97.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

LVCLY
No analyst data
Altman Z
18.1
Piotroski
2/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LVCLY buys
0
FCPT buys
0
No recent congressional trades found for LVCLY or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLVCLYFCPT
Forward yield6535.95%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$847059858510467.75M$49.1K
Annual income after 10y$822,310,439,328,829,700,000.00$5,775.28
Total dividends collected$845398324525487.00M$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: LVCLY vs FCPT ($10,000, DRIP)

YearLVCLY PortfolioLVCLY Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$664,295$653,594.77$11,401$700.92+$652.9KLVCLY
2$41,288,327$40,577,531.69$13,064$864.84+$41.28MLVCLY
3$2,401,225,824$2,357,047,314.22$15,051$1,072.48+$2401.21MLVCLY
4$130,681,438,576$128,112,126,943.84$17,442$1,337.22+$130681.42MLVCLY
5$6,655,923,504,827$6,516,094,365,550.46$20,340$1,677.08+$6655923.48MLVCLY
6$317,290,561,721,524$310,168,723,571,359.44$23,880$2,116.57+$317290561.70MLVCLY
7$14,158,069,430,029,650$13,818,568,528,987,620.00$28,241$2,689.36+$14158069430.00MLVCLY
8$591,419,335,802,228,700$576,270,201,512,097,000.00$33,660$3,442.07+$591419335802.20MLVCLY
9$23,130,298,300,596,280,000$22,497,479,611,287,900,000.00$40,456$4,439.95+$23130298300596.24MLVCLY
10$847,059,858,510,467,700,000$822,310,439,328,829,700,000.00$49,063$5,775.28+$847059858510467.75MLVCLY

LVCLY vs FCPT: Complete Analysis 2026

LVCLYStock

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.

Full LVCLY Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this LVCLY vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LVCLY vs SCHDLVCLY vs JEPILVCLY vs OLVCLY vs KOLVCLY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.